Response to "Letter to the Editor" From David Y. Mak et al
J Thorac Oncol
.
2023 Jan;18(1):e4-e5.
doi: 10.1016/j.jtho.2022.11.014.
Authors
Hirotsugu Kenmotsu
1
,
Keita Mori
2
,
Kazuhiko Nakagawa
3
,
Nobuyuki Yamamoto
4
,
Toshiaki Takahashi
5
Affiliations
1
Division of Thoracic Oncology, Shizuoka Cancer Center, Nagaizumi-cho Sunto-gun, Japan. Electronic address:
[email protected]
.
2
Clinical Research Center, Shizuoka Cancer Center, Nagaizumi-cho Sunto-gun, Japan.
3
Department of Medical Oncology, Kindai University Faculty of Medicine, Osaka, Japan.
4
Internal Medicine III, Wakayama Medical University, Wakayama, Japan.
5
Division of Thoracic Oncology, Shizuoka Cancer Center, Nagaizumi-cho Sunto-gun, Japan.
PMID:
36543438
DOI:
10.1016/j.jtho.2022.11.014
No abstract available
Publication types
Letter
Research Support, Non-U.S. Gov't
Comment
MeSH terms
Humans
Lung Neoplasms*